Presentations.AI Launches White-Label AI Presentation Generator and Editable PowerPoint API for SaaS Companies, Agencies and AI Agents at $0.10 Per Slide With a 50% Launch Discount 
SAP Helps CHKP Group Connect Online and Offline Retail to Deliver Personalised Experiences at AV Life and FOTOMAX 
Vietnam’s E-Commerce Grew 44% in 2026. Its Parcel Count Grew 13.7%, and the Gap Is the Story 
MicroVision Expands Collaboration with FieldAI Across Government and Industrial Autonomous Systems Programs 
Results for Third Quarter Ending 30 September 2026 Challenging Personal Stereotypes in Spotlight at Women Icons Network Collective for Equality Summit
Singapore, Mar 25, 2022 – (ACN Newswire) – Their gender itself is reason enough for…
Memiontec Secures its Largest Contract to date following Award of a New S$56.6 Million Contract by PUB
Singapore, Mar 25, 2022 – (ACN Newswire) – Memiontec Holdings Ltd. (“Memiontec” or the “Company”,…
UserTesting Introduces New Test Templates That Enable Companies to Understand Human Interactions with Connected Devices and the Internet of Things (IoT)
UserTesting helps companies innovate new ways to engage with customers as digital transformation continues to…
Diagnostic Industry Veteran Karin Eastham to Chair Personalis Board of Directors
Personalis’ oncology diagnostics business expected to build on foundation of advanced technology already the driver…
Citizens Financial Group and Investors Bancorp Receive Regulatory Approval for Citizens Acquisition of Investors
Customers will continue to be served through their respective Citizens and Investors branches, websites and…
Statera Biopharma Announces Closing of $5.7 Million Underwritten Public Offering
FORT COLLINS, Colo., March 24, 2022 (GLOBE NEWSWIRE) — Statera Biopharma, Inc. (NASDAQ: STAB) (the…
Landos Biopharma Reports Fourth Quarter and Full Year 2021 Results and Provides Business Update
Continued Progress Towards Optimizing Clinical Development Plans On Track to Initiate Phase 2b Study of…
TFF Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update
Pipeline Advancement Continues with Ongoing Phase 2 Studies for Voriconazole and Tacrolimus Programs Partnership Activity…
Correction: Galapagos publishes 2021 annual report and announces extraordinary and annual shareholders’ meetings
— Proposal of one-tier board structure & appointment of three new directors — Mechelen, Belgium;…
Auxly to Report Fourth Quarter and Full Year 2021 Financial Results on March 31, 2022
TORONTO, March 24, 2022 (GLOBE NEWSWIRE) — Auxly Cannabis Group Inc. (TSX – XLY) (OTCQX:…
Imago BioSciences Reports Fourth Quarter and Full Year 2021 Financial Results
SOUTH SAN FRANCISCO, Calif., March 24, 2022 (GLOBE NEWSWIRE) — Imago BioSciences, Inc. (“Imago”) (Nasdaq:…
Kane Biotech Announces Fourth Quarter and Full Year 2021 Financial Results
WINNIPEG, Manitoba, March 24, 2022 (GLOBE NEWSWIRE) — Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the…
Bellicum Reports Fourth Quarter 2021 Financial Results and Provides Operational Update
– Confirmed partial response in one of the first three metastatic castration-resistant prostate cancer (mCRPC)…
GBT Announces Participation at the Guggenheim Genomic Medicines & Rare Disease Day
SOUTH SAN FRANCISCO, Calif., March 24, 2022 (GLOBE NEWSWIRE) — Global Blood Therapeutics, Inc. (GBT) (NASDAQ:…
SeqLL to Participate in the 2022 Virtual Growth Conference Presented by Maxim Group LLC and hosted by M-Vest
BILLERICA, Mass., March 24, 2022 (GLOBE NEWSWIRE) — SeqLL Inc. (“SeqLL” or the “Company”) (NASDAQ:…
Panbela Provides Business Update and Reports Q4 and FY 2021 Financial Results
MINNEAPOLIS, March 24, 2022 (GLOBE NEWSWIRE) — Panbela Therapeutics, Inc. (Nasdaq: PBLA), a clinical stage company developing…
Athira Pharma Reports Full Year 2021 Financial Results and Provides Clinical Update
On track to report topline data from ACT-AD Phase 2 Alzheimer’s disease study in 2Q22…
89bio Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update
– Reported positive topline results from cohort 7 in the Phase 1b/2a trial including data from…
Erasca Reports Fourth Quarter 2021 Financial Results and Business Updates
Five ongoing clinical trials evaluating candidates ERAS-007 (ERKi), ERAS-601 (SHP2i), and ERAS-801 (CNS-penetrant EGFRi) Initial…
ADMA Biologics Announces Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update, Including $175M Debt Refinance with Hayfin Capital Management
Full Year 2021 Total Revenues of Approximately $81 Million, a 92% Increase Over Full Year…